Figure 1.
Kaplan–Meier curves of prostate cancer patients with: (A) mutation in NSB1 (n=52); (B) mutation in BRCA1 (n=13); (C) mutation in CHEK2 (n=340), compared with prostate cancer patients with no mutation (non-carriers; n=3082).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.